SC 13G/A | 2022-05-27 | ALPHA CAPITAL ANSTALT | Qualigen Therapeutics, Inc. | 3,525,042 | 10.0% | EDGAR |
SC 13G/A | 2022-01-05 | SABBY MANAGEMENT, LLC | Qualigen Therapeutics, Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2021-12-06 | SABBY MANAGEMENT, LLC | Qualigen Therapeutics, Inc. | 1,960,000 | 5.6% | EDGAR |
SC 13G | 2020-06-01 | Greenblock Capital, LLC | Qualigen Therapeutics, Inc. | 811,431 | 6.5% | EDGAR |
SC 13G | 2020-06-01 | SEKISUI DIAGNOSTICS, LLC | Qualigen Therapeutics, Inc. | 1,980,233 | 15.8% | EDGAR |
SC 13G | 2020-05-28 | ALPHA CAPITAL ANSTALT | Qualigen Therapeutics, Inc. | 1,240,088 | 9.9% | EDGAR |
SC 13G/A | 2020-02-14 | Alyeska Investment Group, L.P. | RITTER PHARMACEUTICALS INC | 425,000 | 4.2% | EDGAR |
SC 13G/A | 2020-01-29 | Step Michael D | RITTER PHARMACEUTICALS INC | 128,757 | 0.7% | EDGAR |
SC 13G/A | 2020-01-28 | Stonehenge Partners LLC | RITTER PHARMACEUTICALS INC | 119,197 | 0.6% | EDGAR |
SC 13G/A | 2019-02-14 | Alyeska Investment Group, L.P. | RITTER PHARMACEUTICALS INC | 572,890 | 10.0% | EDGAR |
SC 13G/A | 2019-02-13 | BAKER BROS. ADVISORS LP | RITTER PHARMACEUTICALS INC | 286,499 | 5.0% | EDGAR |
SC 13G/A | 2018-02-14 | Alyeska Investment Group, L.P. | RITTER PHARMACEUTICALS INC | 4,999,371 | 10.0% | EDGAR |
SC 13G | 2018-02-13 | BAKER BROS. ADVISORS LP | RITTER PHARMACEUTICALS INC | 2,800,000 | 5.7% | EDGAR |
SC 13G/A | 2018-01-09 | SABBY MANAGEMENT, LLC | RITTER PHARMACEUTICALS INC | 2,470,375 | 5.0% | EDGAR |
SC 13D/A | 2017-11-28 | Javelin Venture Partners GP, LLC | RITTER PHARMACEUTICALS INC | 7,131,028 | 14.4% | EDGAR |
SC 13D/A | 2017-10-31 | Javelin Venture Partners GP, LLC | RITTER PHARMACEUTICALS INC | 12,131,028 | 22.2% | EDGAR |
SC 13G | 2017-10-03 | SABBY MANAGEMENT, LLC | RITTER PHARMACEUTICALS INC | 4,900,000 | 9.9% | EDGAR |
SC 13G/A | 2017-02-15 | Step Michael D | RITTER PHARMACEUTICALS INC | 948,834 | 7.6% | EDGAR |
SC 13G/A | 2017-02-15 | Stonehenge Partners LLC | RITTER PHARMACEUTICALS INC | 817,271 | 7.0% | EDGAR |
SC 13G/A | 2017-02-14 | Knoll Capital Management, LP | RITTER PHARMACEUTICALS INC | 952,434 | 8.2% | EDGAR |